General Psychiatry
General Psychiatry RSS Feed RSS

Before You Write That Prescription: Guidelines for Ordering Lab Tests

November 1, 2015
Rajnish Mago, MD
Rajnish Mago, MD Director, Mood Disorders Program, Associate Professor of Psychiatry, Thomas Jefferson University Dr. Mago discloses that he has received research grants from Alkermes, Allergan (formerly Forest Laboratories), Genomind, and Takeda, and that he has been a paid consultant to Genomind, Guidepoint Global, Otsuka, and Lundbeck. Dr. Carlat has reviewed this article and found no evidence of bias in this educational activity.
Mental health clinicians often ask for a single, black-and-white answer to the question: Which lab tests should I order before starting this particular medication? Inevitably, the answer is that it depends. Here are some guidelines that are useful.
Read More

Distinguishing Between Medical and Psychiatric Conditions

November 1, 2015
Barbara Schildkrout, MD

TCPR_Nov_Dec2015_BarbaraShildkroutMD_headshot.pngBarbara Schildkrout, MD

Assistant Professor of Psychiatry, Part-Time Harvard Medical School, in the Department of Psychiatry at Beth Israel Deaconess Medical Center, Boston, Massachusetts. Author of “Unmasking Psychological Symptoms” and “Masquerading Symptoms,” both published by John Wiley and Sons, Inc.

Dr. Schildkrout has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Dr. Schildkrout discusses strategies for differentiating medical and psychiatric disorders. The interview covers how mental health professionals can catch red flags for medical conditions such as dimentia and seizures.
Read More

Cariprazine (Vraylar): A drug for negative symptoms? Don’t be positive.

November 1, 2015
Talia Puzantian, PharmD, BCPP
Talia Puzantian, PharmD, BCPP Clinical psychopharmacology consultant in private practice, Los Angeles, CA. www.taliapuzantian.com Dr. Puzantian has disclosed that she has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.
On September 17, the FDA approved cariprazine (Vraylar) for the treatment of schizophrenia and bipolar disorder. There’s already some buzz about whether this medication has advantages over other atypicals for treating negative symptoms of schizophrenia.

Read More

A New Treatment Program Effective for First-Episode Psychosis

November 1, 2015
Daniel Carlat, MD
Daniel Carlat, MD

Editor-in-Chief, Publisher, The Carlat Report.

Dr. Carlat has disclosed that he has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.

Catching patients early in the course of their psychotic disorders may improve outcomes. A new NIMH-funded study compared a very comprehensive treatment program with treatment as usual, and the results were promising.
Read More

Live Chat: What should you know about psychiatric genetic testing?

October 5, 2015
Background:Recently, The Boston Globe ran an article that picked up on The Carlat Psychiatry Report's recent coverage of the GeneSight test. It's a promising technology, but the marketing has leap-frogged ahead of the science. Web Chat Panel: Daniel Carlat, MD, Founder and Editor-in-Chief of The Carlat Psychiatry Report  Beth Daley, Investigative Reporter and Author...
Read More

Telepsychiatry: What You Need to Know

October 1, 2015
Daniel Carlat, MD
Daniel Carlat, MD Editor-in-Chief, Publisher, The Carlat Report. Dr. Carlat has disclosed that he has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.
The appeal of telemedicine is clear, especially for psychiatrists. We are in great demand, and there aren’t enough of us to meet the demand—especially in rural counties. Patients and doctors alike are increasingly realizing that telehealth can save them time and money. Here's the information you need to start practicing online.
Read More

Are Skype, FaceTime, and Google Hangouts HIPAA Compliant?

October 1, 2015
Daniel Carlat, MD
Daniel Carlat, MD Editor-in-Chief, Publisher, The Carlat Report. Dr. Carlat has disclosed that he has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.
Applying HIPAA to telemedicine has proven to be pretty tricky. A decade ago, most of us believed that the only way to ensure secure videoconferencing was to pay for expensive “HIPAA-compliant” videoconferencing equipment. But things are changing.
Read More
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
Featured Video
Featured Podcast
Recommended

About

Shop Online

Newsletters

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.